Insiders · Profile

Werner Milton H.

President and CEO at Inhibikase Therapeutics. Filing since 17 Nov 2021. CIK 0001827621

Company
Date
Role
Action
Shares
Amount
Of holding
16 Aug 2022
President and CEO
Bought
5,000
$4.00K
0.1%
27 May 2022
President and CEO
Bought
5,000
$4.88K
0.1%
20 May 2022
President and CEO
Bought
10,000
$6.00K
0.2%
17 Nov 2021
President and CEO
Bought
23,589
$46.56K
opened
4 decisions on file.